Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-003357-17Phase 4Terminated
Phase 4 trial of esketamine in chronic pancreatitis (CP) (2 arms), sponsored by Prof. Asbjørn Mohr Drewes. Primary endpoints: Pain relief in daily pain diary and Experimental analgesic and anti-hyperalgesic effects. Started Nov 2013; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-003357-17.